Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2019 Jun 3:cebp.0145.2019. doi: 10.1158/1055-9965.EPI-19-0145

Table 1.

Characteristics of Participants by Liver Fibrosis Scores Among Men 40 Years and Older, NHANES 2001–2010

Overall APRI FIB-4 NFS
Normal Abnormala Normal Abnormal Normal Abnormal
Unweighted Participants 6,705 6,541 164 6,319 386 6,139 566
Age group, % (95% CI)
 40 – 49 years 38.0
(36.2–39.9)
37.9
(36.1–39.8)
42.4
(32.3–53.2)
39.0
(37.2–40.9)
11.6
(7.3–17.7)
40.0
(38.1–41.9)
5.2
(3.8–7.1)
 50 – 59 years 31.1
(29.4–32.8)
31.1
(29.5–32.7)
28.6
(19.1–40.3)
31.6
(30.0–33.4)
15.3
(10.5–21.7)
32.0
(30.3–33.8)
14.4
(10.5–19.5)
 60 – 69 years 17.4
(16.5–18.4)
17.4
(16.4–18.4)
18.9
(13.8–25.3)
17.3
(16.3–18.3)
20.2
(15.5–25.9)
16.8
(15.8–17.9)
27.8
(23.4–32.6)
 70 – 79 years 9.6
(9.0–10.3)
9.7
(9.0–10.4)
6.5
(3.7–11.1)
9.0
(8.4–9.7)
25.2
(21.1–29.7)
8.2
(7.6–8.9)
32.8
(29.0–36.7)
 ≥80 years 3.9
(3.5–4.4)
3.9
(3.5–4.4)
3.7
(2.0–6.5)
3.0
(2.6–3.5)
27.8
(23.7–32.3)
3.0
(2.6–3.4)
19.7
(17.0–22.8)
Race/ethnicity, % (95% CI)
 White (non-Hispanic) 77.1
(74.5–79.7)
77.3
(74.7–79.9)
67.4
(57.4–77.4)
77.2
(74.6–79.7)
76.4
(71.0–81.9)
77.0
(74.2–79.5)
79.8
(75.4–83.6)
 Black (non-Hispanic) 8.6
(7.3–9.8)
8.5
(7.2–9.7)
14.4
(8.6–20.1)
8.5
(7.3–9.7)
10.6
(7.3–13.8)
8.6
(7.4–9.9)
8.3
(6.2–11.0)
 Mexican-American/Other Hispanic 9.6
(7.7–11.5)
9.5
(7.6–11.4)
12.5
(6.5–18.6)
9.7
(7.8–11.6)
7.1
(4.1–10.1)
9.8
(8.0–11.9)
6.6
(4.8–9.0)
 Other 4.7
(3.8–5.6)
4.7
(3.7–5.6)
5.7
(0.7–10.7)
4.7
(3.7–5.6)
5.9
(2.7–9.1)
4.7
(3.8–5.7)
5.4
(3.5–8.1)
Education level, % (95% CI)
 Less than 9th grade 7.4
(6.5–8.2)
7.3
(6.4–8.1)
11.0
(5.9–16.2)
7.1
(6.3–7.9)
14.3
(10.7–17.9)
6.9
(6.1–7.8)
15.0
(11.3–19.6)
 9–11th grade (includes 12th grade, no diploma) 10.2
(9.2–11.3)
10.1
(9.0–11.1)
18.5
(10.3–26.7)
10.1
(9.0–11.1)
15
(10.1–19.9)
10.1
(9.1–11.3)
11.6
(9.2–14.6)
 High school graduate/GED or equivalent 25.2
(23.8–26.6)
25.0
(23.6–26.4)
33.1
(24.7–41.6)
25.2
(23.8–26.6)
24.6
(18.6–30.6)
25.5
(23.9–26.6)
24.8
(21.0–29.0)
 Some college or associates degree 27.4
(26.0–28.9)
27.5
(26.1–29.0)
22.4
(14.4–30.4)
27.6
(26.2–29.1)
21.8
(16.0–27.7)
27.4
(26.0–29.0)
27.3
(21.5–34.1)
 College graduate or above 29.8
(27.6–32.0)
30.1
(27.9–32.3)
14.9
(7.2–22.6)
30.0
(27.7–32.2)
24.3
(18.1–30.5)
30.3
(28.0–32.6)
21.3
(16.9–26.4)
Drinking status, % (95% CI)
 Non-drinker or non-heavy drinker 91.2
(90.3–92.1)
91.6
(90.8–92.5)
70.2
(62.3–78.1)
91.4
(90.5–92.3)
85.7
(81.4–90.1)
91.0
(90.0–91.9)
94.2
(91.6–96.0)
 Heavy drinker 8.8
(7.9–9.7)
8.4
(7.5–9.2)
29.8
(21.9–37.7)
8.6
(7.7–9.5)
14.3
(9.9–18.6)
9.0
(8.1–10.0)
5.8
(4.0–8.4)
Smoking history, % (95% CI)
 Never 41.7
(39.7–43.6)
42.1
(40.1–44.1)
23.9
(14.6–33.3)
41.9
(39.9–43.9)
35.2
(29.7–40.7)
42.1
(40.0–44.1)
35.3
(31.1–39.8)
 Ever 58.3
(56.4–60.3)
57.9
(55.9–59.9)
76.1
(66.7–85.4)
58.1
(56.1–60.1)
64.8
(59.3–70.3)
57.9
(55.9–60.0)
64.7
(60.2–68.9)
BMI category, % (95% CI)
 Normal/overweight (<30 kg/m2) 65.4
(63.7–67.2)
65.5
(63.8–67.3)
62.0
(52.9–71.1)
65.3
(63.5–67.1)
69.1
(63–75.2)
67.4
(65.6–69.1)
32.5
(28.8–36.4)
 Obese (≥30 kg/m2) 34.6
(32.8–36.3)
34.5
(32.7–36.2)
38.0
(28.9–47.1)
34.7
(32.9–36.5)
30.9
(24.8–37.0)
32.6
(30.9–34.4)
67.5
(63.6–71.2)
Diabetes status, % (95% CI)
 No diabetes 63.5
(62.1–65.0)
63.6
(62.2–65.0)
61.9
(52.8–71.0)
64.0
(62.5–65.4)
51.7
(44–59.5)
65.9
(64.4–67.3)
24.5
(20.6–28.9)
 At risk for diabetes 22.5
(21.4–23.7)
22.6
(21.4–23.8)
17.5
(9.6–25.3)
22.4
(21.2–23.7)
24.8
(19.2–30.4)
22.3
(21.1–23.6)
25.4
(21.2–30.1)
 Controlled diabetes 5.8
(5.0–6.6)
5.7
(4.9–6.6)
7.7
(2.9–12.5)
5.5
(4.7–6.3)
12.5
(7.0–18.0)
4.5
(3.8–5.4)
26.7
(22.1–32.0)
 Uncontrolled diabetes 8.2
(7.3–9.1)
8.1
(7.2–9.0)
12.9
(6.1–19.7)
8.1
(7.2–9.0)
10.9
(7.4–14.4)
7.3
(6.4–8.2)
23.4
(19.1–28.3)
Self-reported liver disease, % (95% CI)
 Never 95.2
(94.5–95.8)
95.6
(95.0–96.2)
75.7
(64.7–84.1)
95.6
(94.9–96.2)
85.1
(78.8–89.8)
95.4
(94.6–96.0)
92.4
(88.4–95.1)
 Ever 4.8
(4.2–5.5)
4.4
(3.8–5.0)
24.3
(15.9–35.3)
4.4
(3.8–5.1)
14.9
(10.2–21.2)
4.6
(4.0–5.4)
7.6
(4.9–11.6)
HCV status, % (95% CI)
 HCV negative 96.7
(96.0–97.3)
97.4
(96.7–97.9)
65.3
(55.6–74.0)
97.1
(96.4–97.6)
86.2
(80.4–90.4)
96.7
(96.0–97.3)
96.1
(93.4–97.7)
 HCV infected 3.3
(2.7–4.0)
2.6
(2.1–3.3)
34.7
(26.0–44.4)
2.9
(2.4–3.6)
13.8
(9.6–19.6)
3.3
(2.7–4.0)
4.0
(2.3–6.6)
HBV status, % (95% CI)
 Negative 92.2
(91.2–93.0)
92.4
(91.5–93.3)
79.2
(70.0–86.1)
92.4
(91.4–93.3)
85.6
(79.8–89.9)
92.3
(91.3–93.2)
90.1
(86.6–92.7)
 Current or previous HBV infected 7.8
(7.0–8.8)
7.6
(6.7–8.5)
20.8
(13.9–30.0)
7.6
(6.7–8.6)
14.4
(10.1–20.2)
7.7
(6.8–8.7)
9.9
(7.3–13.4)
 Chronic HBV infected 0.5
(0.3–0.7)
0.5
(0.3–0.7)
1.2
(3.5–4.0)
0.5
(0.3–0.7)
0.5
(0.2–1.7)
0.5
(0.3–0.7)
0.3
(0.1–1.2)
a

Cutpoint for abnormal liver fibrosis score equates to advanced fibrosis (APRI >1, FIB-4 >2.67 and NFS >0.676).